Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9531938 | 0.89 | TBXA2R (0.46) | L3MBTL1SIRT2RXFP1CYP11B1CYP11B2 | |
| SCHEMBL9528880 | 0.85 | L3MBTL1 (0.41) | L3MBTL1SIRT2KDM4EMAOBAOC3 | |
| SCHEMBL9527584 | 0.84 | LMNA (0.43) | L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL9529174 | 0.78 | LTA4H (0.39) | L3MBTL1ALDH1A1 | |
| SCHEMBL9529212 | 0.78 | MAPT (0.44) | SLC2A1L3MBTL1KDM4EALDH1A1CYP11B1 | |
| SCHEMBL9529604 | 0.76 | TBXA2R (0.52) | L3MBTL1ALDH1A1 | |
| SCHEMBL9530556 | 0.72 | MAPT (0.43) | ALDH1A1 | |
| SCHEMBL9529150 | 0.68 | CYP4F2 (0.41) | L3MBTL1KDM4EALOX15ALDH1A1 | |
| SCHEMBL9531940 | 0.67 | TBXA2R (0.65) | — | |
| Hydrochloric Acid SCHEMBL11447923 | 0.67 | L3MBTL1 (0.52) | L3MBTL1KDM4EALOX15ALDH1A1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0366006-B1 | PYRIDYLKETOXIME ETHER COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-4971985-A | ANTIISCHEMIC AGENTS, CARDIOVASCULAR DISORDERS | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1990-11-20 | — | — | US | disclosed |